EGCG (Epigallocatechin Gallate) Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about EGCG (Epigallocatechin Gallate) dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for EGCG (Epigallocatechin Gallate).
Dosing Protocols
Beginner Protocol — Daily Green Tea Consumption and Foundation Support
Goal: Establish green tea-based EGCG intake as a foundational daily health practice with minimal complexity and excellent safety margin.
Protocol:
- Green tea 2-4 cups daily (brewed traditionally, 2-3 minutes steep time, 1 tsp loose leaves or 1 tea bag per cup)
- OR matcha tea 1-2 servings daily (1/2 to 1 teaspoon matcha powder whisked into hot water)
- OR decaffeinated green tea extract 200-300 mg total polyphenols (approximately 100-150 mg EGCG) once daily with breakfast
- Duration: ongoing daily use
Rationale: Regular green tea consumption provides EGCG at dietary levels with optimal safety profile. This approach is backed by the strongest evidence (population studies showing cardiovascular mortality reduction at 5+ cups daily). Matcha provides whole-leaf consumption with L-theanine and higher EGCG. Decaffeinated extract eliminates caffeine concerns for users who prefer supplementation.
Optional additions:
- Vitamin D3 2000-5000 IU daily
- Omega-3 2-3 g EPA+DHA daily
- L-theanine 100-200 mg for additional calm focus (naturally present in green tea)
Monitoring: No specific laboratory monitoring required at this dose in healthy adults. If using supplementation long-term, annual liver function panel is prudent.
Expected timeline: Biomarker changes (oxidative stress markers, modest lipid improvement) detectable at 4-8 weeks. Cardiovascular benefits accrue over years of consistent use.
Budget: Green tea beverage: $10-25/month. Decaffeinated green tea extract: $15-30/month.
Intermediate Protocol — Metabolic and Cardiovascular Biomarker Support
Goal: Achieve the biomarker effects (lipid profile improvement, blood pressure reduction, glucose metabolism improvement) documented in clinical trials for moderate-risk populations.
Protocol:
- Green tea extract providing 300-400 mg EGCG daily (from standardized extract, decaffeinated preferred to avoid caffeine concerns)
- Take with breakfast; split into twice-daily dosing (breakfast + lunch) for sustained plasma levels
- Combined with supporting supplements:
- Omega-3 fatty acids 2-3 g EPA+DHA daily
- Vitamin D3 2000-5000 IU daily
- CoQ10 100-200 mg daily (cardiovascular support)
- Magnesium 200-400 mg daily (cardiovascular, metabolic)
Rationale: 300-400 mg EGCG daily provides the dose range most consistently showing biomarker effects in meta-analyses. Twice-daily dosing provides more sustained plasma levels. Decaffeinated format eliminates caffeine-related concerns. Supporting supplements provide complementary cardiovascular and metabolic support. Take with food to minimize hepatotoxicity risk.
Monitoring: Annual liver function panel (ALT, AST, bilirubin, alkaline phosphatase), comprehensive metabolic panel, lipid panel, complete blood count. Consider iron studies if risk factors for iron deficiency.
Expected timeline: Biomarker effects detectable at 8-12 weeks of consistent use. Continued benefit accrues over months to years.
Budget: $30-60/month for green tea extract plus supporting stack.
Advanced Protocol — Clinical-Trial Dosing for Specific Applications
Goal: Achieve the doses used in specific clinical trials (cancer chemoprevention, weight management, type 2 diabetes) while maintaining appropriate medical monitoring for hepatotoxicity.
Protocol:
- EGCG (from standardized high-purity extract) 400-800 mg daily
- Split into twice-daily dosing (400 mg morning + 400 mg afternoon) — always taken with food
- Form: Polyphenon E, Teavigo, or similar high-quality standardized extract
- Combined with comprehensive longevity stack:
- NAC 600-1200 mg daily (hepatoprotective, glutathione substrate)
- Alpha-lipoic acid 600 mg daily (hepatoprotective antioxidant)
- Milk thistle 400-800 mg daily (hepatoprotective)
- Selenium 200 mcg daily
- Vitamin E 400 IU mixed tocopherols daily (antioxidant regeneration)
- Curcumin phytosome 1000 mg daily
- Omega-3 3-4 g EPA+DHA daily
- Vitamin D3 5000 IU daily
Rationale: This dose range approaches the upper EFSA safety threshold (800 mg/day) and corresponds to many clinical trial doses. The hepatoprotective supporting stack (NAC, alpha-lipoic acid, milk thistle) provides protection against potential hepatotoxic effects — an important safety margin at these doses. Twice-daily dosing improves tolerability and efficacy. Always take with food; never fasted.
Monitoring: Quarterly liver function panel during initial 6 months, then semi-annually. Comprehensive metabolic panel, lipid panel, complete blood count every 6 months. Iron studies annually. Discontinue immediately if ALT/AST rise above 2x upper limit of normal.
Expected timeline: Full stack effects develop over 6-12 months. Specific clinical endpoints (cancer biomarkers like PSA for prostate cancer research) may require longer observation.
Budget: $100-200/month for comprehensive stack depending on product selection.
Physician coordination: Advanced protocols approaching the 800 mg EGCG daily upper safety threshold benefit from physician oversight for liver function monitoring, particularly if other hepatotoxic risk factors exist (alcohol use, medications affecting liver, pre-existing liver disease).
Specific applications:
- Prostate cancer HGPIN (after Bettuzzi 2006): 600 mg EGCG daily (as Polyphenon E) with oncology/urology coordination.
- Weight management: 400-600 mg EGCG + caffeine 100-200 mg before meals; combined with caloric restriction and exercise.
- Type 2 diabetes adjunct: 400 mg EGCG daily with food, with diabetes medication adjustment monitoring.
- NAFLD: 300-400 mg EGCG with hepatologist coordination and LFT monitoring.
Adjustments for specific populations:
- Pregnancy: Limit to dietary green tea consumption (1-2 cups); avoid high-dose supplementation due to folate antagonism and neural tube defect concerns.
- Hepatic impairment: Avoid high-dose supplementation; limit to dietary green tea.
- Iron deficiency: Separate timing from iron sources by 1+ hour; consider low-dose supplementation only.
- Caffeine sensitivity: Use decaffeinated green tea extract (Teavigo) or matcha in very moderate amounts.
- Anticoagulation therapy: Consistent daily green tea consumption is manageable; avoid high-dose supplementation.
Not applicable — EGCG is oral only. No injection, intranasal, or standard topical systemic formulations are commercially established. Topical EGCG is used in some specialized applications (genital HPV lesions, specific dermatological conditions) but not for systemic effect.
Topical EGCG applications in research include photoaging treatment, HPV-related lesions (Veregen prescription topical), and some dermatological conditions. These are local-effect applications rather than systemic supplementation.
Commonly Stacked With
EGCG combines productively with multiple supplements in cardiovascular, metabolic, weight management, cognitive, and longevity supplementation regimens. Several of its most-studied combinations are industry staples.
EGCG + caffeine (classical weight loss combination): The most studied EGCG combination. Caffeine enhances lipolysis through PDE inhibition; EGCG enhances fat oxidation through AMPK activation and COMT inhibition (prolonging catecholamine effects). Combined produces modest enhanced thermogenesis and weight loss in overweight adults. Typical doses: green tea extract providing 200-400 mg EGCG + 100-200 mg caffeine 30-60 minutes before meals or exercise. This combination underlies many commercial "fat burner" products.
EGCG + l-theanine: L-theanine is naturally present in green tea alongside EGCG and provides complementary anxiolytic and cognitive effects to the caffeine and EGCG combination. Natural-ratio green tea provides EGCG + L-theanine + caffeine in balanced proportions. For users wanting the specific combination: EGCG 200-400 mg + L-theanine 100-200 mg ± caffeine 50-100 mg.
EGCG + curcumin: Both anti-inflammatory polyphenols with complementary mechanisms. Curcumin provides NF-kB inhibition and broader inflammatory pathway modulation; EGCG adds kinase inhibition and Nrf2 activation. Reasonable foundational anti-inflammatory stack. Typical doses: EGCG 200-400 mg + curcumin phytosome 500-1000 mg daily.
EGCG + resveratrol or pterostilbene: Complementary polyphenol mechanisms — stilbenes for SIRT1 activation, catechins for additional antioxidant and kinase effects. Typical doses: EGCG 200-400 mg + pterostilbene 50-100 mg daily.
EGCG + quercetin: Both flavonoids with overlapping anti-inflammatory mechanisms. Quercetin adds mast cell stabilization and zinc ionophore activity; EGCG adds 67LR binding and kinase inhibition. Reasonable for users pursuing broad flavonoid coverage. Typical doses: EGCG 200-400 mg + quercetin 500-1000 mg daily.
EGCG + sulforaphane: Complementary cellular defense activation — EGCG provides kinase inhibition and antioxidant effects while sulforaphane provides more potent Nrf2 activation. Reasonable pairing for comprehensive antioxidant and anti-inflammatory support. Typical doses: EGCG 200-400 mg + Avmacol Active 1-2 tablets daily.
EGCG + berberine: Both activate AMPK; berberine more potently. Combination reasonable for metabolic support in prediabetes or type 2 diabetes. Typical doses: EGCG 400 mg + berberine 500 mg 2-3x daily.
EGCG + omega-3 fatty acids: Foundational cardiovascular combination. Omega-3 provides membrane EPA/DHA; EGCG provides antioxidant protection to polyunsaturated fats plus independent cardiovascular benefits.
EGCG + fisetin: Fisetin for intermittent senolytic pulse dosing; EGCG for chronic daily anti-inflammatory and metabolic support.
EGCG + apigenin: Complementary flavonoid coverage. Apigenin provides CD38 inhibition/NAD+ preservation and GABA-A effects; EGCG provides kinase inhibition and cardiovascular benefits.
Weight management stack: EGCG 400 mg (from caffeinated green tea extract) + caffeine 200 mg (can be from the same product) + green tea phytosome for bioavailability + protein-forward diet. Modest additive effect on weight loss beyond caloric restriction alone.
Cardiovascular support stack: EGCG 300 mg + omega-3 2-3 g EPA+DHA + CoQ10 100-200 mg + vitamin D 2000-5000 IU daily. Comprehensive cardiovascular biomarker and function support.
Diabetes support stack: EGCG 400 mg + berberine 500 mg 2-3x daily + alpha-lipoic acid 600 mg + chromium 200 mcg + cinnamon 1-2 g daily. Integrated glycemic support alongside standard medical therapy.
Stacks to use cautiously:
- EGCG + stimulant weight loss drugs (phentermine, ephedrine-like compounds): Additive cardiovascular stimulation; avoid high-dose EGCG with prescription stimulant weight loss agents.
- EGCG + other hepatotoxic substances (alcohol, acetaminophen at high doses): Additive hepatotoxicity risk; reduce EGCG dose or avoid.
- EGCG + iron supplements: Separate timing by 1+ hour.
- EGCG + warfarin: Inconsistent green tea consumption is problematic; either be consistent or avoid supplementation.
- EGCG + nadolol: Green tea reduces nadolol bioavailability; avoid combination.
- EGCG + anticancer chemotherapy (cisplatin, bortezomib, some tyrosine kinase inhibitors): Potential drug interaction; oncology team consultation required.
- High-dose EGCG in fasted state: Hepatotoxicity risk; always take with food at high doses.
Product selection notes:
- Whole green tea or matcha: Traditional whole-food delivery; provides EGCG alongside L-theanine, caffeine, and other catechins in natural ratios; safest overall; lower EGCG per serving.
- Decaffeinated green tea extract: Teavigo or similar; eliminates caffeine-related side effects; preserves EGCG content; good for stimulant-sensitive users.
- Standardized green tea extract (50-80% polyphenols): Standard commercial format; reasonable balance of EGCG content and safety; prefer brands with third-party testing.
- High-purity EGCG (>90%): Maximum EGCG per dose; higher hepatotoxicity risk; reserve for specific therapeutic applications with medical oversight.
- Green tea phytosome or liposomal: Enhanced bioavailability allowing lower doses for equivalent effects; good option for users pursuing benefits without high doses.
- Avoid unbranded concentrated weight loss supplements: These have been the primary source of hepatotoxicity case reports; prefer reputable established brands.
Side Effects & Safety
Contraindications
**Absolute contraindications:** - **Pre-existing severe hepatic impairment:** Avoid high-dose EGCG supplementation; dietary green tea may be acceptable with clinician guidance. - **Pregnancy (high-dose supplementation):** Neural tube defect concerns from animal studies; limit to dietary green tea consumption. - **Known allergy to green tea or catechins:** Rare but possible. - **Concurrent use of nadolol:** Green tea/EGCG reduces nadolol bioavailability substantially; avoid combination. **Relative contraindications (discuss with physician before use):** - **Chronic alcohol use:** Additive hepatotoxic potential; reduce or avoid high-dose EGCG supplementation. - **Concurrent use of acetaminophen at therapeutic or toxic doses:** Potential hepatotoxic interaction. - **Iron deficiency anemia:** EGCG reduces iron absorption; separate timing or avoid high doses. - **Anticoagulation therapy (warfarin):** Vitamin K content of green tea interferes with warfarin; inconsistent green tea consumption is problematic. - **Active cancer under chemotherapy:** Some chemotherapy drug interactions documented; oncology team consultation required. - **Cardiovascular arrhythmia with caffeine sensitivity:** Use decaffeinated products only. - **Severe anxiety or insomnia:** Avoid caffeinated green tea extract, particularly in evening. - **Pre-existing liver enzyme elevations:** Obtain hepatology clearance before high-dose supplementation. - **Kidney disease:** No specific contraindication but use at lower doses. - **Upcoming surgical procedures:** Discontinue EGCG supplementation 7-10 days before surgery due to mild antiplatelet effects. **Caution populations:** - **Adults over 75 years:** Start at lower doses; monitor liver function more frequently. - **Polypharmacy users:** Multiple drug interactions possible via CYP modulation; physician awareness. - **Pregnant women with folate deficiency concerns:** Ensure adequate folate; avoid high-dose EGCG. - **Iron-deficient populations (menstruating women, vegetarians, frequent blood donors):** Monitor iron status. **Drug interactions requiring monitoring:** - Warfarin and other anticoagulants (vitamin K and antiplatelet considerations) - Iron-containing medications/supplements - Nadolol and some beta-blockers - Aspirin and NSAIDs (additive antiplatelet) - Stimulants (additive caffeine effects if caffeinated form) - MAO inhibitors (theoretical catecholamine effects) - Some chemotherapy agents (cisplatin, bortezomib, tyrosine kinase inhibitors) - Lithium (theoretical reduction through diuresis) **Discontinue immediately and seek medical attention if:** - Jaundice (yellowing of skin or eyes) - Dark urine or pale stools - Severe fatigue or weakness - Abdominal pain in the right upper quadrant - Severe nausea and vomiting - Signs of hepatic dysfunction - Significant unexplained bleeding or bruising - Severe allergic reaction
Additional Notes
Dose-response relationships: EGCG's clinical effects span a wide dose range. Population-level cardiovascular benefits are observed at dietary green tea consumption (5+ cups daily, providing approximately 100-200 mg EGCG). Supplement-based biomarker effects (lipid, blood pressure, glucose) emerge at 200-400 mg daily. Specific clinical applications (weight management, chemoprevention research) have been tested at 400-800 mg daily. Above 800 mg daily, hepatotoxicity risk increases without clear additional benefit.
Standard supplementation doses:
- Foundation support: 100-200 mg EGCG daily (typical low-dose extract or 2-3 cups green tea)
- Biomarker targeting: 200-400 mg EGCG daily
- Weight management: 300-500 mg EGCG + caffeine 100-200 mg before meals
- Cardiovascular/diabetes research doses: 400-800 mg EGCG daily
- Not recommended: >800 mg EGCG daily without medical supervision
Bioavailability considerations: EGCG has low baseline oral bioavailability (0.1-1.5%) with extensive first-pass metabolism. Enhancement strategies include: (1) fasted administration — 2-3x higher plasma levels but substantially increased hepatotoxicity risk; not recommended; (2) phytosome or liposomal formulations — 3-8x higher bioavailability at equivalent doses; reasonable for users wanting lower doses with similar effects; (3) piperine co-administration — modest enhancement; (4) combination with other catechins (natural green tea matrix) — modest effects through microbial metabolism and synergy. For most users, moderate-dose standard extracts taken with food provide appropriate balance of efficacy and safety.
Timing: EGCG's plasma half-life of 1-3 hours means single doses provide limited sustained exposure. However, many downstream effects (Nrf2 activation, kinase inhibition) persist longer. For weight management applications, pre-meal dosing is reasonable. For cardiovascular and general support, morning dosing with breakfast is typical. For high-dose protocols, twice-daily dosing provides more sustained exposure.
Food interaction: Always take with food to minimize hepatotoxicity risk and gastrointestinal upset. Separate timing from iron-containing meals or supplements by at least 1 hour. Calcium-containing foods (dairy) can chelate catechins and reduce absorption — consider separating if maximum absorption is desired.
Storage: Protect from light, heat, and moisture. EGCG is moderately stable but degrades over time. Respect expiration dates.
Quality verification: Prefer products specifying:
- EGCG content per serving (not just total polyphenol content)
- Standardization to specific EGCG percentage
- Third-party purity testing
- Heavy metal testing
- Reputable brand reputation
Avoid:
- "Weight loss" products with concentrated EGCG and stimulants from unverified manufacturers
- Products without clear EGCG content disclosure
- Products claiming extreme doses (>1000 mg EGCG per serving)
- Products combining high-dose EGCG with hepatotoxic ingredients
Dosing for specific goals:
- General longevity and antioxidant: 200-400 mg EGCG daily with food
- Weight management adjunct: 300-500 mg EGCG + caffeine 100-200 mg 30-60 min before meals
- Cardiovascular biomarker support: 300-400 mg EGCG daily with food
- Type 2 diabetes adjunct: 400 mg EGCG daily with meals
- Prostate cancer chemoprevention research: 600 mg EGCG daily (physician-supervised)
Not recommended doses:
- Above 800 mg EGCG daily without medical supervision (hepatotoxicity concern)
- Fasted administration at high doses
- Combination with alcohol or other hepatotoxic substances
- Pediatric dosing (not established)
- High-dose supplementation during pregnancy
Loading doses or cycling: EGCG does not require a loading dose. Cycling is not necessary; chronic daily use at appropriate doses is appropriate. Some users prefer periodic breaks (e.g., 6 weeks on, 2 weeks off) for personal preferences; this is not clinically necessary.
Frequently Asked Questions
What is the recommended EGCG (Epigallocatechin Gallate) dosage?
Dosage for EGCG (Epigallocatechin Gallate) varies by protocol. Consult a qualified healthcare provider.
How often should I take EGCG (Epigallocatechin Gallate)?
Administration frequency depends on the specific protocol. Consult current research literature.
Does EGCG (Epigallocatechin Gallate) need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are EGCG (Epigallocatechin Gallate) side effects?
EGCG safety is characterized by an excellent safety record at dietary and moderate supplementation doses but with specific hepatotoxicity concerns at high concentrated supplementation doses that require careful understanding. **Gastrointestinal effects (most common):** Mild stomach upset, nausea, constipation, or diarrhea occur in 5-15% of supplement users. Worse with fasted administration; take with food to minimize. Caffeine content of non-decaffeinated products contributes to some GI effects. **Hepatotoxicity (most serious, dose-dependent):** The primary serious safety concern with EGCG. Concentrated high-dose EGCG supplements (particularly >800 mg daily, fasted, or in susceptible individuals) can cause liver enzyme elevations and rarely severe hepatitis. EFSA 2018 systematic review established 800 mg daily as the upper safety threshold for supplementary EGCG. Case reports describe acute hepatitis with jaundice, liver enzyme elevations to 1000-5000 U/L, and rarely progression to liver failure. Most cases resolve with discontinuation but some have required liver transplantation. Risk factors include: high doses (>800 mg/day), fasted administration, combination with other hepatotoxic substances (alcohol, some medications), individual susceptibility (possibly genetic polymorphisms), weight loss products containing concentrated EGCG. Green tea beverage consumption at dietary levels (1-8 cups daily) is not associated with hepatotoxicity. Practical guidance: limit supplemental EGCG to 400-500 mg daily for most users, take with food, avoid fasted state, monitor liver function if using >500 mg daily, discontinue immediately if symptoms of jaundice, dark urine, or severe fatigue develop. **Iron absorption interference:** EGCG chelates iron and reduces non-heme iron absorption substantially (up to 50% reduction when taken with iron-containing meals). Clinically significant in individuals with borderline iron status, menstruating women, vegetarians, frequent blood donors, or those with iron deficiency anemia. Take EGCG separately from iron-containing meals (at least 1 hour apart) if iron status is a concern. Some individuals may develop iron deficiency with chronic high-dose EGCG use. **Caffeine-related effects (non-decaffeinated products):** Green tea contains caffeine (approximately 20-40 mg per cup, up to 100+ mg per high-dose extract). Caffeine-related effects include jitteriness, anxiety, insomnia, heart palpitations, and headache in sensitive individuals. Decaffeinated products (Teavigo, decaf green tea extract) eliminate these effects. **Headache:** Mild headache is reported occasionally, often resolving with continued use or dose reduction. **Sleep disruption:** Evening EGCG consumption (particularly of caffeinated forms) can disrupt sleep in caffeine-sensitive individuals. **Anxiety and palpitations:** Caffeine content of green tea extracts can produce anxiety and palpitations in sensitive individuals, particularly at high doses. **Drug interactions:** - **Warfarin:** Green tea contains vitamin K and may reduce warfarin effectiveness; EGCG itself has mild antiplatelet activity. Consistent green tea intake is manageable with warfarin dose adjustment; high-dose supplementation is less predictable. - **Iron-containing medications/supplements:** EGCG reduces iron absorption. - **Stimulants (caffeine, amphetamines, decongestants):** Additive caffeine effects if EGCG product contains caffeine. - **Antihypertensives:** Theoretical additive blood pressure reduction. - **Nadolol and some beta-blockers:** Green tea reduces nadolol bioavailability; avoid high-dose green tea extract with nadolol. - **Aspirin and NSAIDs:** Additive antiplatelet effects at high EGCG doses. - **Cisplatin and some chemotherapy agents:** Potential reduction of anticancer effect (case reports); discuss with oncology team. - **MAO inhibitors:** Theoretical interaction via COMT inhibition and catecholamine potentiation. **Pregnancy:** High-dose EGCG has been associated with neural tube defects in animal models through folate antagonism. Pregnant women should avoid high-dose EGCG supplementation. Dietary green tea consumption (1-2 cups daily) is generally considered safe during pregnancy. **Lactation:** Green tea beverage consumption is compatible with breastfeeding in moderate amounts. High-dose supplementation should be avoided. **Pediatric use:** Pediatric EGCG supplementation is generally not recommended due to hepatotoxicity concerns. Dietary green tea may be consumed by older children in moderate amounts. **Anxiety and mood:** Some users report anxiety or mood changes with high-dose EGCG, particularly caffeinated forms. **Mucosal irritation:** Topical EGCG preparations (e.g., for genital HPV lesions) can cause local irritation, redness, or burning sensation. **Allergic reactions:** Rare but possible with green tea allergy. **Blood glucose effects:** EGCG lowers blood glucose modestly. Diabetic patients on insulin or sulfonylureas should monitor for hypoglycemia. **Overall tolerability grade:** Excellent at dietary levels (green tea beverage consumption 1-5 cups daily) and good at moderate supplementation (200-400 mg EGCG daily taken with food). Caution required at high supplementation doses (>500 mg/day) with specific attention to hepatotoxicity, iron deficiency, and medication interactions. The hepatotoxicity concern is real but dose-dependent and largely avoidable with appropriate dose selection and with-food administration.
Where can I buy EGCG (Epigallocatechin Gallate)?
Visit our vendor directory to find trusted sources for EGCG (Epigallocatechin Gallate).
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
